Assessing bleeding risk in very premature babies with low platelets
Part of Blood & lymphatic, Genetic & congenital clinical trials.
This trial looks at how to estimate bleeding risk in newborns who are very premature and have a low platelet count. The goal is to guide safer care by better identifying which babies may be at higher risk of bleeding.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be born before 32 weeks of pregnancy and weigh at least 500 grams
- Have a low platelet count (below 100)
- Have a parent or guardian who can sign the consent paperwork
- Be expected to live more than 24 hours (according to the baby’s doctor)
- Not be suspected of having an inherited (family) platelet problem
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at the best way to decide when to give platelet transfusions to very premature babies. It aims to help prevent bleeding while avoiding unnecessary transfusions.
This study compares two different amounts of platelet transfusions to see which is safer and more effective for premature babies with very low platelet counts. Platelets are tiny cells in the blood that help stop bleeding, so this treatment may reduce the risk of serious bleeding in the brain.
This study looks at a new way to predict if patients with blood cancers and very low platelets will have bleeding problems. By doing extra blood tests, researchers hope to create a score that helps doctors prevent bleeds.
This study tests a machine called ROTEM Sigma that measures how well your blood clots, specifically in pregnant women who have or may have low platelet counts (cells that help blood clot). The goal is to help doctors better predict bleeding problems during or after delivery.
This trial tests how well platelet transfusions work for patients with blood cancers or bone marrow failure who have very low platelets and need a transfusion. It aims to see if the transfusions help control bleeding and improve outcomes.
This study tests whether giving platelet transfusions to critically ill patients with very low platelet counts helps prevent dangerous bleeding. If you're in the ICU with a very low platelet count, this trial might help decide the best way to keep you safe.
Hear when a new Bleeding trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.